bioRxiv · 10.1101/278416
Intracellular FMRpolyG-HSP70 complex: Possible use as biochemical marker of Fragile X Tremor Ataxia Syndrome
Abstract
INTRODUCTION INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION Author Contributions AKNOWLEDGMENTS CONFLICT OF INTEREST References Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder that affects about 25% of carriers of non-coding CGG-repeat expansions (55-200 repeats) in the premutation range within the fragile X gene (FMR1). Main clinical features include intention tremor, cerebellar ataxia, and Parkinsonism [1]. Recently, great emphasis on the pathogenetic role of toxic aggregates, produced by a RAN translation process on the 5 expanded CGG region, has been given [2,3]. These aggregates contain a small protein with a polyglycin stretch, (FMRpolyG), a ...
Explore related subjects
Keep this discovery
Bonapace, G., Gullace, R., Concolino, D., Iannello, G., Procopio, R., Gagliardi, M., Arabia, G., Barbagallo, G., Lupo, A., Manfredini, L. I., Annesi, G., Quattrone, A.. 2018-03-07. Intracellular FMRpolyG-HSP70 complex: Possible use as biochemical marker of Fragile X Tremor Ataxia Syndrome. https://doi.org/10.1101/278416
Cite the original work for its findings. Save a collection to share your selection of sources.